These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4795903)

  • 1. Inhibition of purine nucleotide metabolism by 6-methylthiopurine ribonucleoside and structurally related compounds.
    Shantz GD; Smith CM; Fontenelle LJ; Lau HK; Henderson JF
    Cancer Res; 1973 Nov; 33(11):2867-71. PubMed ID: 4795903
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of diazoacetyl-glycine amide on purine nucleotide metabolism in Ehrlich ascites tumour cells.
    Giraldi T; Baldini L
    Biochem Pharmacol; 1974 Jan; 23(2):289-93. PubMed ID: 4813345
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of actinomycin D on purine ribonucleotide metabolism in Ehrlich ascites tumor cells in vitro.
    Snyder FF; Henderson JF
    Can J Biochem; 1974 Mar; 52(3):263-7. PubMed ID: 4364138
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of 6-methylthiopurine ribonucleoside 5'-phosphate.
    Ho DH
    Biochem Pharmacol; 1971 Dec; 20(12):3538-9. PubMed ID: 4332207
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of purine ribonucleotide and phosphoribosyl pyrophosphate synthesis by 6-cyclopentylthio-9-hydroxymethylpurine and structurally related compounds.
    Smith CM; Fontenelle LJ; Lalanne M; Henderson JF
    Cancer Res; 1974 Mar; 34(3):463-7. PubMed ID: 4359876
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of methylthioinosine on nucleotide concentrations in L5178Y cells.
    Warnick CT; Paterson AR
    Cancer Res; 1973 Jul; 33(7):1711-5. PubMed ID: 4737232
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.
    Lau KF; Henderson JF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):95-109. PubMed ID: 4499907
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitors of hypoxanthine metabolism in Ehrlich ascites tumor cells in vitro.
    Smith CM; Zombor G; Henderson JF
    Cancer Treat Rep; 1976 Oct; 60(10):1567-84. PubMed ID: 191189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinetic analysis of purine nucleotide synthesis and interconversion in intact Ehrlich ascites tumor cells.
    Snyder FF; Henderson JF
    J Cell Physiol; 1973 Dec; 82(3):349-61. PubMed ID: 4798034
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphorylation of adenosine and deoxyadenosine in Ehrlich ascites carcinoma cells resistant to 6-(Methylmercapto)purine ribonucleoside.
    Lomax CA; Henderson JF
    Can J Biochem; 1972 Apr; 50(4):423-7. PubMed ID: 4537315
    [No Abstract]   [Full Text] [Related]  

  • 12. Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro.
    Crabtree GW; Henderson JF
    Cancer Res; 1971 Jul; 31(7):985-91. PubMed ID: 5560389
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of purine nucleotide biosynthesis by 3-deazaguanine, its nucleoside and 5'-nucleotide.
    Streeter DG; Koyama HH
    Biochem Pharmacol; 1976 Nov; 25(21):2413-5. PubMed ID: 1033766
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the nucleotide metabolism of Ehrlich ascites tumour cells during their growth in vivo.
    Siems W; Schmidt H; Werner A; Uerlings I; David H; Gerber G
    Cell Mol Biol; 1989; 35(3):255-62. PubMed ID: 2776171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenine metabolism of Ehrlich mouse ascites cells in proliferating and resting phase of tumor growth.
    Grune T; Siems W; Uhlig R; Jakstadt M
    Biochem Int; 1992 Feb; 26(2):199-209. PubMed ID: 1558533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nucleoside analogs on purine nucleotide metabolism.
    Henderson JF; Smith CM; Snyder FF; Zombor G
    Ann N Y Acad Sci; 1975 Aug; 255():489-500. PubMed ID: 1059370
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved methods for the study of drug effects on purine metabolism and their application to nebularine and 7-deazanebularine.
    Smith CM; Snyder FF; Fontenelle LJ; Henderson JF
    Biochem Pharmacol; 1974 Jul; 23(14):2023-35. PubMed ID: 4371446
    [No Abstract]   [Full Text] [Related]  

  • 18. Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.
    Siems WG; Grune T; Schmidt H; Tikhonov YV; Pimenov AM
    Cancer Res; 1993 Nov; 53(21):5143-7. PubMed ID: 8221650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutamine oxidation and the purine nucleotide cycle for adaptation of tumour energetics to the transition from the anaerobic to the aerobic state.
    Kovacević Z; Jerance D; Brkljac O
    Biochem J; 1988 Jun; 252(2):381-6. PubMed ID: 3415660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of purine ribonucleotide catabolism in Ehrlich ascites tumor cells in vitro.
    Crabtree GW; Henderson JF
    Can J Biochem; 1971 Aug; 49(8):959-63. PubMed ID: 5165993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.